Sign in
Not yet recruitingNo phase

EARLY-SARDS: Early AlveolaR Lung biologY Underling Sepsis-Associated ARDS

Key facts

Who runs it
Hospital Universitari Vall d'Hebron Research Institute
Where
Spain1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
145 people, planned
Started
15 Oct 2026
Expected to end
1 Mar 2029
Type of study
Observational
Treatments tested
  • Serial bronchoalveolar lavage and biological-physiological assessment
Record updated
28 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age ≥18 years
  • Sepsis or septic shock according to Sepsis-3 criteria
  • Requirement for invasive mechanical ventilation within 72 hours of sepsis diagnosis
  • Written informed consent provided by the participant or a legally authorized representative

Who cannot take part

  • Previous lung transplantation
  • Pregnancy
  • Contraindication to bronchoscopy or bronchoalveolar lavage (BAL).Inability to complete at least two BAL procedures during the 96-hour study period
  • Expected death within 24 hours or limitation of life-sustaining treatment at enrollment
  • Written informed consent not obtained

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Sepsis-associated acute respiratory distress syndrome (ARDS) remains a major cause of respiratory failure and mortality in critically ill patients. Although only a proportion of patients with sepsis develop ARDS, early identification of those at highest risk remains a major unmet clinical need. Current prediction relies largely on clinical deterioration and oxygenation impairment, which often occur when lung injury has already developed. Increasing evidence suggests that biological responses to sepsis are compartmentalized between the systemic circulation and the alveolar space, while early abnormalities in respiratory mechanics and ventilatory efficiency may provide complementary information on evolving lung injury. However, no prospective study has integrated serial systemic and alveolar biomarkers with bedside respiratory physiology during the earliest phase of sepsis-associated respiratory failure.

Read full original descriptionShow less

EARLY-SARDS is a prospective observational cohort study designed to characterize the early biological and physiological trajectories of invasively ventilated patients with sepsis or septic shock. Serial bronchoalveolar lavage (BAL) and plasma samples, together with standardized measurements of respiratory mechanics and gas exchange, will be collected during the first 96 hours after enrollment. The primary objective is to develop an integrated biological-physiological model capable of predicting ARDS development and subsequent peak ARDS severity. Secondary objectives include characterizing biological compartmentalization, identifying integrated biological-physiological subphenotypes, and evaluating their association with clinically relevant outcomes, including duration of mechanical ventilation, ventilator-free days, need for extracorporeal respiratory support, ICU length of stay, and mortality.

The group in the trial

  • Sepsis or Septic shock requiring mechanical ventilation

    Adult ICU patients with sepsis or septic shock requiring invasive mechanical ventilation within 72 hours from sepsis diagnosis will be consecutively enrolled and followed for 96 hours after sepsis diagnosis.

    Treatment: Serial bronchoalveolar lavage and biological-physiological assessment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Characterization of Early Biological and Mechanical Profiles in Sepsis-Associated ARDS for Studying Compartmentalization (Serial Bronchoalveolar Lavage and Plasma Biomarkers) to Identify Inflammatory and Hybrid Subphenotypes
Record updated
28 August 2026